期刊文献+

环氧化酶-2-765G>C基因多态性与结直肠癌易感性关系的Meta分析 被引量:2

Cyclooxygenase-2-765G 〉 C polymorphism and susceptibility to colorectal cancer: a meta-analysis
原文传递
导出
摘要 目的 探讨环氧化酶-2(COX-2)-765G>C基因多态性与结直肠癌(CRC)易感性的关联.方法 计算机检索Pubmed、EMABSE、CJFD、CBM、CNKI、VIP及万方数据库,检索时间截至2013年3月1日,收集关于COX-2-765G>C基因多态性与结直肠癌易感性的病例-对照研究,初筛得到99篇文献.由2名评价者按照纳入和排除标准独立选择文献、提取资料、评价质量,采用RevMan 5.1和Stata12.0软件进行Meta分析.结果 最终纳入11个病例-对照研究,包括3432例患者和5286名对照.纳入的结果除在GC/GG基因型的比较模型中存在异质性(I2 =52%,P=0.03)外,其他三种遗传模型同质性较好.各遗传模型Meta分析结果显示:COX-2-765G>C基因多态性与结直肠癌易感性的关联性无统计学意义[显性遗传模型:(GC+ CC)/GG:OR=1.08,95% CI:0.96 ~ 1.21;隐性遗传模型:CC/(GC+ GG):OR=1.09,95% CI:0.76~ 1.56;共显性遗传模型:GC/GG:OR=1.05,95% CI:0.87 ~ 1.28;CC/GG:OR=1.11,95% CI:0.77~1.60].基于人群的亚组分析显示:COX-2-765G>C基因多态性可增加黄种人群罹患结直肠癌的风险[(GC+ CC)/GG:OR=1.41,95% CI:1.15 ~ 1.75;GC/GG:OR=1.48,95% CI:1.15~1.90],而对白种人群结直肠癌易感性无明显关联.结论 COX-2-765G>C基因多态性可增加黄种人群结直肠癌的易感性. Objective To explore the correlation between polymorphism of cyclooxygenase-2 (COX-2)-765G > C and susceptibility to colorectal cancer.Methods All eligible case-control studies published up to March 2013 were searched out from PubMed,EMABSE,CJFD,CBM,CNKI,VIP and WanFang databases,while 99 articles were concluded.Two reviewers independently identified the literature according to inclusion and exclusion criteria.Meta-analysis was performed using RevMan 5.1 and Stata 12.0 software.Results A total of eleven studies comprising 3432 cases and 5286 controls were finally included.The included studies showed good homogeneity in the three genetic models,except the model of GC/GG genotype (I2 =52%,P =0.03).Overall,there were no significant association between polymorphism of COX-2-765 G > C and the susceptibility to colorectal cancer (dominant model:(GC + CC)/GG:OR =1.08,95% CI:0.96-1.21 ; recessive model:CC/(GC + GG):OR =1.09,95% CI:0.76-1.56; GC/GG:OR =1.05,95% CI:0.87-1.28; CC/GG:OR =1.11,95% CI:0.77-1.60).In stratification analysis by ethnicity,we observed that the polymorphism of COX-2-765G > C could increase the susceptibility to colorectal cancer among yellow populations ((GC + CC)/GG:OR =1.41,95% CI:1.15-1.75 ; GC/ GG:OR =1.48,95% CI:1.15-1.90),but there was no significant association found among Caucasian populations.Conclusion This meta-analysis suggested that the polymorphism of COX-2-765G > C may increase the susceptibility to colorectal cancer in the yellow population.
出处 《中华预防医学杂志》 CAS CSCD 北大核心 2014年第1期62-66,共5页 Chinese Journal of Preventive Medicine
关键词 环氧化酶2 结肠肿瘤 META分析 多态现象 遗传 Cyclooxygenase 2 Colonic neoplasms Meta-analysis Polymorphism,genetics
  • 相关文献

参考文献4

二级参考文献37

  • 1Jia-Li Liu, Zhen-Ning Wang, Department of Surgical Oncology and General Surgery, the First Affiliated Hospital of China Medical University, Shenyang 110001, Liaoning Province, China Yuan Liang, Department of Oncology, the Shengjing Affiliated Hospital of China Medical University, Shenyang 110001, Liaoning Province, China Xin Zhou, Department of Obstetrics and Gynecology, the Shengjing Affiliated Hospital of China Medical University, Shenyang 110001, Liaoning Province, China Li-Li Xing, Department of Oncology, the Fourth Affiliated Hospital of China Medical University, Shenyang 110032, Liaoning Province, China.Cyclooxygenase-2 polymorphisms and susceptibility to gastric carcinoma: A meta-analysis[J].World Journal of Gastroenterology,2010,16(43):5510-5517. 被引量:5
  • 2Carina Pereira,Hugo Sousa,Paula Ferreira,Maria Fragoso,Luís Moreira-Dias,Carlos Lopes,Rui Medeiros,Mário Dinis-Ribeiro.-765G > C COX-2 polymorphism may be a susceptibility marker for gastric adenocarcinoma in patients with atrophy or intestinal metaplasia[J].World Journal of Gastroenterology,2006,12(34):5473-5478. 被引量:16
  • 3Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994; 107: 1183-1188
  • 4Williams CS, Mann M, DuBois RN. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 1999; 18: 7908-7916
  • 5Bosetti C, Gallus S, La Vecchia C. Aspirin and cancer risk: an updated quantitative review to 2005. Cancer Causes Control 2006; 17: 871-888
  • 6Goodman JE, Bowman ED, Chanock SJ, Alberg AJ, Harris CC. Arachidonate lipoxygenase (ALOX) and cyclooxygenase (COX) polymorphisms and colon cancer risk. Carcinogenesis 2004; 25: 2467-2472
  • 7Siezen CL, Bueno-de-Mesquita HB, Peeters PH, Kram NR, van Doeselaar M, van Kranen HJ. Polymorphisms in the genes involved in the arachidonic acid-pathway, fish consumption and the risk of colorectal cancer. Int J Cancer 2006; 119: 297-303
  • 8Ulrich CM, Whitton J, Yu JH, Sibert J, Sparks R, Potter JD, Bigler J. PTGS2 (COX-2) -765G > C promoter variant reduces risk of colorectal adenoma among nonusers of nonsteroidal anti-inflammatory drugs. Cancer Epidemiol Biomarkers Prev 2005; 14: 616-619
  • 9Cox DG, Pontes C, Guino E, Navarro M, Osorio A, Canzian F, Moreno V. Polymorphisms in prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) and risk of colorectal cancer. Br J Cancer 2004; 91: 339-343
  • 10Wiesner GL, Platzer P, Buxbaum S, Lewis S, MacMillen M, Olechnowicz J, Willis J, Chakravarti A, Elston RC, Markowitz SD. Testing for colon neoplasia susceptibility variants at the human COX2 locus. J Natl Cancer Inst 2001; 93: 635-639

共引文献21

同被引文献43

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部